Skip to main content
Figure 2 | BMC Neurology

Figure 2

From: Preliminary study: Treatment with intramuscular interferon beta-1a results in increased levels of IL-12Rβ2+ and decreased levels of IL23R+ CD4+ T - Lymphocytes in multiple sclerosis

Figure 2

Flow Cytometry of IL-12Rβ2 + CD4 + T cells from MS patients before, 24 hr and 7 d after treatment with beta-interferon. (A) Results of one representative patient. (B) Percentage of IL-12Rβ2+ T cells from MS patients shows that at 24 hours post treatment that there is an increase in this cell type that almost reaches statistical significance. Values are expressed as mean ± SEM. (C) Percentage of CD4+T cells expressing IL-12β2 in each MS patient treated with beta-interferon (n = 6).

Back to article page